Katherine High
Direktor/Vorstandsmitglied bei CRISPR THERAPEUTICS AG
Vermögen: 3 Mio $ am 31.05.2024
Profil
Dr. Katherine A.
High, MD, is an Independent Director at Incyte Corp.
and an Independent Director at CRISPR Therapeutics AG.
She is on the Board of Directors at Incyte Corp., CRISPR Therapeutics AG, Innovative Genomics Institute and Virion Therapeutics LLC.
Dr. High was previously employed as a Director & President-Therapeutics by Asklepios BioPharmaceutical, Inc., a President, Head-Research & Development by Spark Therapeutics, Inc., a Director-Center For Cellular by The Children's Hospital of Philadelphia, a Professor by Perelman School of Medicine, and a President by American Society of Gene & Cell Therapy.
She received her undergraduate degree from Harvard University, a graduate degree from the University of Pennsylvania and a doctorate degree from UNC School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INCYTE CORPORATION
0,02% | 15.04.2024 | 48 220 ( 0,02% ) | 3 Mio $ | 31.05.2024 |
CRISPR THERAPEUTICS AG
-.--% | 30.05.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Katherine High
| Unternehmen | Position | Beginn |
|---|---|---|
| CRISPR THERAPEUTICS AG | Direktor/Vorstandsmitglied | 11.06.2019 |
| INCYTE CORPORATION | Direktor/Vorstandsmitglied | 25.03.2020 |
Virion Therapeutics LLC
 Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Direktor/Vorstandsmitglied | - |
| Innovative Genomics Institute | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Katherine High
| Unternehmen | Position | Ende |
|---|---|---|
Asklepios BioPharmaceutical, Inc.
 Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Direktor/Vorstandsmitglied | 01.12.2022 |
| SPARK THERAPEUTICS, INC. | Gründer | 01.02.2020 |
| Perelman School of Medicine | Corporate Officer/Principal | 01.09.2014 |
The Children's Hospital of Philadelphia
 The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01.04.2014 |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Präsident | - |
Ausbildung von Katherine High
| Harvard University | Undergraduate Degree |
| University of Pennsylvania | Graduate Degree |
| UNC School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| CRISPR THERAPEUTICS AG | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc. BiotechnologyHealth Technology Asklepios BioPharmaceutical, Inc. operates as a gene therapy-based company. It engages in capsid development, scaled manufacturing, and a portfolio of therapeutic programs. The company was founded by Richard Jude Samulski, Xiao Xiao, and Sheila A. Mikhail in 2001 and is headquartered in Durham, NC. | Health Technology |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | Health Services |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Commercial Services |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Virion Therapeutics LLC develops chronic viral disease vaccines. It offers ChiVax and ChiVax-gD vaccines. The firm engages in developing immune-based treatments for virally-associated cancers and chronic viral infections. The company was founded by Bernard C. Rudnick, Hildegund C. J. Ertl and Andrew D. Luber in 2018 and is headquartered in Newark, DE. | Health Technology |
| Innovative Genomics Institute |
